Johnson & Johnson
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Johnson & Johnson (JNJ) Business News
Track Johnson & Johnson in real time with a live news feed covering Johnson & Johnson stock news, official press releases, company announcements, and an archive of historical Johnson & Johnson news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold?
DNB Asset Management AS Sells 94,911 Shares of Johnson & Johnson $JNJ
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash
Andra AP fonden Sells 7,100 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Purchased by AlphaCore Capital LLC
Are You Looking for a High-Growth Dividend Stock?
Can J&J Sustain Its Double-Digit Oncology Growth Streak?
Johnson & Johnson $JNJ Shares Bought by Empirical Asset Management LLC
Wall Street Bulls Look Optimistic About Johnson & Johnson (JNJ): Should You Buy?
First Look: Gilead buys Arcellx; IBM sinks on AI; Bitcoin slides
J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold?
11:05 AM | Friday | Feb 27, 2026
Johnson & Johnson's JNJ stock has risen 38.4% in the past six months. The stock has also been trading above its 50-day and 200-day simple moving averages (SMAs) for more than eight months since mid-June 2025 due to its positive earnings outlook and improving fundamentals.
Read full article
J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold?
Zacks Investment ResearchJohnson & Johnson's JNJ stock has risen 38.4% in the past six months. The stock has also been trading above its 50-day and 200-day simple moving averages (SMAs) for more than eight months since mid-June 2025 due to its positive earnings outlook and improving fundamentals.
Read full article
DNB Asset Management AS Sells 94,911 Shares of Johnson & Johnson $JNJ
Defense WorldDNB Asset Management AS cut its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 7.6% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,161,215 shares of the company's stock after selling 94,911 shares during the period. Johnson and Johnson
Read full article
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash
The Motley FoolJohnson & Johnson's diversified healthcare business can thrive even in a downturn. The company's outstanding dividend program can help offset market losses.
Read full article
Andra AP fonden Sells 7,100 Shares of Johnson & Johnson $JNJ
Defense WorldAndra AP fonden lowered its position in Johnson and Johnson (NYSE: JNJ) by 3.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 201,600 shares of the company's stock after selling 7,100 shares during the period. Andra AP fonden's
Read full article
Johnson & Johnson $JNJ Shares Purchased by AlphaCore Capital LLC
Defense WorldAlphaCore Capital LLC lifted its position in Johnson and Johnson (NYSE: JNJ) by 20.2% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,848 shares of the company's stock after acquiring an additional 5,343 shares during the quarter. AlphaCore
Read full article
Are You Looking for a High-Growth Dividend Stock?
Zacks Investment ResearchDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Read full article
Can J&J Sustain Its Double-Digit Oncology Growth Streak?
Zacks Investment ResearchJohnson & Johnson JNJ is one of the key pharmaceutical players in the oncology segment with significant expertise in blood cancers and solid tumors. It is the #1 company in multiple myeloma, with key drug Darzalex being considered the foundational gold standard treatment.
Read full article
Johnson & Johnson $JNJ Shares Bought by Empirical Asset Management LLC
Defense WorldEmpirical Asset Management LLC grew its holdings in Johnson and Johnson (NYSE: JNJ) by 80.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,582 shares of the company's stock after acquiring an additional 4,280 shares during the period. Empirical
Read full article
Wall Street Bulls Look Optimistic About Johnson & Johnson (JNJ): Should You Buy?
Zacks Investment ResearchThe recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read full article
First Look: Gilead buys Arcellx; IBM sinks on AI; Bitcoin slides
GuruFocusStock News Dimon warns on credit cycle: JPMorgan Chase (JPM) CEO Jamie Dimon cautioned that elevated asset prices and growing banking competition echo preâ200
Read full article